NDC to RxNorm Crosswalk 43485-102 Spritam

View RxNorm Concepts, RxCUIs, Term Types

RxNorm Crosswalk Information

This drug is included in the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States.

The RxNorm crosswalk for NDC code 43485-102 indicates multiple RxNorm Concept Unique Identifiers known as RxCUIs associated to the product Spritam . The unique RxCUI concepts linked to this product are: 1736037, 1736044, 1736045, 1736047, 1736048, 1736050, 1736051 and 1736053. RxCUIs are identifiers that group each chemically distinct drug into a single code regardless of manufacturer or package size. Drugs mapped to the same RxCUI are considered the same drug as having the same ingredients, strengths, and dose forms. The RxNorm mapping may include repeated RxCUI concepts with different descriptions and term types.

RxCUI: 1736037

Concept: levETIRAcetam 1000 MG Tablet for Oral Suspension: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: levetiracetam 1000 MG Tablet for Oral Suspension: Term Type (TTY): SCD - Semantic Clinical Drug
Ingredient + Strength + Dose Form

Concept: levetiracetam 1000 MG Tablet for Oral Suspension: Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 1736044

Concept: Spritam 1000 MG Tablet for Oral Suspension: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: levetiracetam 1000 MG Tablet for Oral Suspension [Spritam]: Term Type (TTY): SBD - Semantic Branded Drug
Ingredient + Strength + Dose Form + Brand Name

Concept: Spritam 1000 MG Tablet for Oral Suspension: Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 1736045

Concept: levETIRAcetam 250 MG Tablet for Oral Suspension: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: levetiracetam 250 MG Tablet for Oral Suspension: Term Type (TTY): SCD - Semantic Clinical Drug
Ingredient + Strength + Dose Form

Concept: levetiracetam 250 MG Tablet for Oral Suspension: Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 1736047

Concept: Spritam 250 MG Tablet for Oral Suspension: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: levetiracetam 250 MG Tablet for Oral Suspension [Spritam]: Term Type (TTY): SBD - Semantic Branded Drug
Ingredient + Strength + Dose Form + Brand Name

Concept: Spritam 250 MG Tablet for Oral Suspension: Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 1736048

Concept: levETIRAcetam 500 MG Tablet for Oral Suspension: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: levetiracetam 500 MG Tablet for Oral Suspension: Term Type (TTY): SCD - Semantic Clinical Drug
Ingredient + Strength + Dose Form

Concept: levetiracetam 500 MG Tablet for Oral Suspension: Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 1736050

Concept: Spritam 500 MG Tablet for Oral Suspension: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: levetiracetam 500 MG Tablet for Oral Suspension [Spritam]: Term Type (TTY): SBD - Semantic Branded Drug
Ingredient + Strength + Dose Form + Brand Name

Concept: Spritam 500 MG Tablet for Oral Suspension: Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 1736051

Concept: levETIRAcetam 750 MG Tablet for Oral Suspension: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: levetiracetam 750 MG Tablet for Oral Suspension: Term Type (TTY): SCD - Semantic Clinical Drug
Ingredient + Strength + Dose Form

Concept: levetiracetam 750 MG Tablet for Oral Suspension: Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 1736053

Concept: Spritam 750 MG Tablet for Oral Suspension: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: levetiracetam 750 MG Tablet for Oral Suspension [Spritam]: Term Type (TTY): SBD - Semantic Branded Drug
Ingredient + Strength + Dose Form + Brand Name

Concept: Spritam 750 MG Tablet for Oral Suspension: Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

What is RxNorm?

RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.

The goal of RxNorm is to facilitate the efficient exchange of drug information among the computer systems used by hospitals, pharmacies, clinics and other organizations. To achieve this goal RxNorm provides normalized names and unique identifiers for drugs and medicines.

What is an RXCUI?

An RxCUI is machine readable unique identifier that defines the same common concept. Every name and code provided to the National Library of Medicine receives an RXCUI. Drug products that map to the same RxCUI are considered the same drug while drugs that are distinct will have different RxCUIs.

What is a Term Type (TTY)?

Term Types (TTYs) are used to specify the level of complexity of each RxCUI term.

* This product uses publicly available data courtesy of the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.